A. Soriano Corporation (PSE:ANS)

Revance Therapeutics Balance Sheet

Financials in millions PHP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,163	3,438	3,215	2,948	2,729	3,092
Trading Asset Securities	14,663	15,414	12,998	12,047	11,678	10,023
Cash & Short-Term Investments	17,826	18,851	16,214	14,995	14,407	13,115
Cash Growth	-0.35%	16.27%	8.13%	4.08%	9.85%	9.20%
Accounts Receivable	2,459	2,361	2,127	2,202	1,756	1,690
Other Receivables	-	353.34	293.97	240.42	248.07	234.21
Receivables	2,459	2,714	2,421	2,442	2,004	1,924
Inventory	1,828	2,115	1,757	1,695	1,625	1,053
Prepaid Expenses	356.85	105.43	404.68	190.81	44.81	36.74
Other Current Assets	376.7	37.68	14.52	16.36	12.84	28.76
Total Current Assets	22,846	23,823	20,811	19,340	18,094	16,157
Property, Plant & Equipment	3,980	4,007	3,837	2,723	2,558	2,502
Long-Term Investments	2,021	1,987	393.34	395.88	374.18	410.51
Goodwill	1,302	1,302	1,302	1,302	1,302	1,302
Other Intangible Assets	-	7.31	9.62	3.65	4.9	7.01
Long-Term Deferred Tax Assets	81.31	85.32	118.24	114.12	111.52	124
Other Long-Term Assets	735.18	708.97	804.29	1,014	883.18	792.17
Total Assets	31,330	32,309	27,693	25,138	23,625	21,602
Accounts Payable	1,019	462.32	370.8	415.78	346	314.69
Accrued Expenses	-	352.53	336.34	307.13	251.99	207.3
Short-Term Debt	335	670	-	-	23.17	23.17
Current Portion of Long-Term Debt	70.91	104.55	-	-	75.71	151.43
Current Portion of Leases	37.4	0.47	18.76	10.13	9.81	4.92
Current Income Taxes Payable	114.75	60.4	77.03	90.71	138.91	206.87
Current Unearned Revenue	-	61.23	77.12	101.12	76.1	54.29
Other Current Liabilities	1,195	1,293	1,171	1,021	956.22	647.62
Total Current Liabilities	2,772	3,005	2,051	1,946	1,878	1,610
Long-Term Debt	675.46	675.45	1,000	-	-	75.71
Long-Term Leases	-	37.4	35.3	9.08	6.79	19.21
Long-Term Deferred Tax Liabilities	484.46	539.43	493.57	417.85	521.28	468.39
Other Long-Term Liabilities	377.34	94.27	101.72	111.74	113.73	111.41
Total Liabilities	4,328	4,370	3,705	2,525	2,568	2,342
Common Stock	2,500	2,500	2,500	2,500	2,500	2,500
Additional Paid-In Capital	1,724	1,724	1,724	1,859	1,859	1,859
Retained Earnings	24,135	25,107	21,347	20,022	18,449	16,866
Treasury Stock	-2,655	-2,655	-2,655	-2,655	-2,655	-2,655
Comprehensive Income & Other	369.55	387.4	252.09	230.26	302.1	125.5
Total Common Equity	26,074	27,064	23,168	21,957	20,456	18,696
Minority Interest	922.96	869.74	814.99	652.01	596.53	564.82
Shareholders' Equity	27,002	27,939	23,988	22,614	21,057	19,260
Total Liabilities & Equity	31,330	32,309	27,693	25,138	23,625	21,602
Total Debt	1,119	1,488	1,054	19.22	115.48	274.44
Net Cash (Debt)	16,707	17,364	15,160	14,976	14,292	12,840
Net Cash Growth	-1.06%	14.54%	1.23%	4.79%	11.30%	11.96%
Net Cash Per Share	13.59	14.14	12.35	12.20	11.64	10.34
Filing Date Shares Outstanding	1,228	1,228	1,228	1,228	1,228	1,228
Total Common Shares Outstanding	1,228	1,228	1,228	1,228	1,228	1,228
Working Capital	20,074	20,819	18,759	17,394	16,216	14,547
Book Value Per Share	21.24	22.05	18.87	17.89	16.66	15.23
Tangible Book Value	24,772	25,754	21,856	20,651	19,148	17,386
Tangible Book Value Per Share	20.18	20.98	17.80	16.82	15.60	14.16
Land	-	3,273	3,116	2,926	2,857	2,828
Machinery	-	3,920	3,708	2,597	2,279	2,088
Construction In Progress	-	241.74	243.2	185.47	133.2	15.25

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.